CDT Equity Inc. Common Stock (CDT)

About CDT

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diab…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

4

Website

www.cdtequity.com/

Fundamentals

1-day range

$1.62$2.03

Market cap

$1.81M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-6483.69

Dividend yield

—

Beta

1.48

Avg. volume

665.5K

CDT Equity Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• CDT

  CDT Equity Inc. Common Stock

  $1.69

  ▼ 10.37%
  Market cap $1.81MP/E —
  $1.62$2,928
• MTNB

  Matinas Biopharma Holdings Inc. Common Stock

  $0.1966

  ▼ 1.70%
  Market cap $1.93MP/E —
  $0.178$2.14
• OGEN

  Oragenics Inc. Common Stock

  $0.5296

  ▼ 0.08%
  Market cap $2.39MP/E —
  $0.4801$1.45
• SBFM

  Sunshine Biopharma Inc. Common Stock

  $1.16

  ▼ 8.66%
  Market cap $2.48MP/E —
  $1.01$24.3
• BDRX

  Biodexa Pharmaceuticals plc American Depositary Shs

  $0.8351

  ▼ 7.21%
  Market cap $1.06MP/E —
  $0.8303$59.4
• ARTL

  Artelo Biosciences Inc. Common Stock

  $0.6619

  ▲ 0.14%
  Market cap $2.59MP/E —
  $0.52$28.14
• BCTXZ

  BriaCell Therapeutics Corp. Warrant expiring 2030

  $0.135

  ▲ 12.31%
  Market cap $782.1KP/E —
  $0.0551$0.52

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• CDT Equity Announced That New Solid Forms And Alternative Crystal Structures Of Its Existing Drug Compounds, Show Enhanced Physical Property Advantages, Including Improved Stability, Solubility, Manufacturability, Over Existing Forms Of These Compounds
  benzinga · 8/28/2026
• 12 Health Care Stocks Moving In Tuesday's Intraday Session
  Benzinga · 8/25/2026
• Why Cadeler Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
  Benzinga · 8/25/2026
• Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
  Benzinga · 8/25/2026
• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/21/2026
• CDT Equity Enters Securities Purchase Agreement With Sarborg Investors On July 30, 2026; To Buy 4.76% Of Sarborg
  Benzinga · 7/31/2026

• Taylor Mark Andrew · June 18, 2026 · Sale

  593.3K @ $1.4
• Taylor Mark Andrew · June 18, 2026 · Sale

  5.0K @ $0.7052
• Taylor Mark Andrew · June 18, 2026 · Sale

  1.46M @ $1.44
• Regan Andrew · May 13, 2026 · Grant

  100.0K @ $1.9
• Regan Andrew · March 24, 2026 · Conversion

  147.4K @ $0.0001
• Regan Andrew · March 24, 2026 · Grant

  147.4K
• Taylor Mark Andrew · March 17, 2026 · J

  51.16M
• Taylor Mark Andrew · March 17, 2026 · J

  51.42M